BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 25, 2011
 |  BC Week In Review  |  Company News  |  Deals

Aduro BioTech, BioSante deal

Aduro received exclusive, worldwide rights to BioSante's GVAX cancer vaccines to treat pancreatic and prostate cancer for use in combination with its Listeria monocytogenes bacterial vectors. Aduro also has the option to license...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >